These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7555194)
21. Essentials in the diagnosis and management of peripheral arterial disease. Medina-Ruiz A; Sánchez-Vélez ME P R Health Sci J; 2004 Dec; 23(4):313-8. PubMed ID: 15776695 [TBL] [Abstract][Full Text] [Related]
22. Invited commentary. Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO). Kashyap VS J Vasc Surg; 2010 Mar; 51(3):609. PubMed ID: 20206805 [No Abstract] [Full Text] [Related]
23. The use of glycoprotein IIb/IIIa antagonists in peripheral arterial occlusion. Ouriel K Tech Vasc Interv Radiol; 2001 Jun; 4(2):107-10. PubMed ID: 11981796 [TBL] [Abstract][Full Text] [Related]
24. Hemorrhagic complications during long-term postoperative warfarin administration in patients undergoing lower extremity arterial bypass surgery. Johnson WC; Williford WO; Corson JD; Padberg FT Vascular; 2004; 12(6):362-8. PubMed ID: 15895759 [TBL] [Abstract][Full Text] [Related]
25. A multi-modal approach to the management of bypass graft failure. Greenberg RK; Ouriel K Vasc Med; 1998; 3(3):215-20. PubMed ID: 9892514 [TBL] [Abstract][Full Text] [Related]
26. [Systemic and regional fibrinolytic treatment of peripheral arterial occlusions: proven indications?]. Kröger K Hamostaseologie; 2006 Aug; 26(3):214-9. PubMed ID: 16906238 [TBL] [Abstract][Full Text] [Related]
27. [Local fibrinolysis of peripheral arterial occlusions]. Schwarzenberg H Rofo; 1998 Sep; 169(3):227-35. PubMed ID: 9779061 [TBL] [Abstract][Full Text] [Related]
28. Pentoxifylline in arterial disease of the legs. Verhaeghe R; Verstraete M Eur J Clin Pharmacol; 1991; 41(6):507-9. PubMed ID: 1815961 [No Abstract] [Full Text] [Related]
30. [The status of thrombolysis in treatment of peripheral arterial occlusive diseases]. Tjon-a-Meeuw L; Schneider E; Bollinger A Internist (Berl); 1992 Apr; 33(4):232-40. PubMed ID: 1612847 [No Abstract] [Full Text] [Related]
31. Sirolimus-eluting stents versus the superficial femoral artery: second round. Oliva VL; Soulez G J Vasc Interv Radiol; 2005 Mar; 16(3):313-5. PubMed ID: 15758126 [No Abstract] [Full Text] [Related]
32. Structured surveillance of patients with peripheral arterial occlusive disease after peripheral vascular interventions. Weiss N; Bergert H Vasa; 2009 Nov; 38(4):302-15. PubMed ID: 19998251 [TBL] [Abstract][Full Text] [Related]
33. [Fibrinolytic treatment of severe arteriopathies of the lower limbs]. Bonnet J; Brottier L; Colle JP; Bricaud H Haemostasis; 1986; 16 Suppl 4():90-3. PubMed ID: 3770562 [No Abstract] [Full Text] [Related]
34. The role of antithrombotic therapy on the patency of peripheral bypasses. Bucek RA; Schnürer G; Ahmadi A; Polterauer P; Kretschmer G; Minar E Vasa; 2000 Aug; 29(3):163-7. PubMed ID: 11037712 [TBL] [Abstract][Full Text] [Related]
35. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy. Marrapodi E; Leanza D; Giordano S; Nazzari M; Corsi C Clin Trials Metaanal; 1994 Apr; 29(1):21-30. PubMed ID: 10150182 [TBL] [Abstract][Full Text] [Related]
36. [Thrombolytic therapy of thromboembolic occlusive diseases of major arteries of the lower extremities]. Rodionov SV; Farber AIa; Butenko AV; Safonov MV Vestn Khir Im I I Grek; 1990 May; 144(5):129-33. PubMed ID: 2175973 [No Abstract] [Full Text] [Related]